Imperva (IMPV) Tops Q1 EPS by 7c

Imperva (NASDAQ: IMPV) reported Q1 EPS of $0.26, $0.07 better than the analyst estimate of $0.19. Revenue for the quarter came in at $84.2 million versus the consensus estimate of $83.74 million.

For earnings history and earnings-related data on Imperva (IMPV) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• OceanaGold to acquire Ausgold in a deal valued at A$776M
• Palo Alto Networks (PANW) PT Raised to $400 at TD Cowen